市场调查报告书
商品编码
1422804
2024-2032 年按类型(全自动、半自动)、应用(医院、诊断实验室、放射诊所等)和地区分類的自动放射合成模组市场报告Automated Radiosynthesis Module Market Report by Type (Fully Automated, Semi-Automated), Application (Hospitals, Diagnostic Labs, Radiology Clinics, and Others), and Region 2024-2032 |
2023年,全球自动放射合成模组市场规模达到3,410万美元。展望未来, IMARC Group预计到2032年市场规模将达到5,710万美元,2024-2032年复合年增长率(CAGR)为5.72%。各种慢性病和心血管疾病的盛行率不断上升,尤其是在老年族群中,加上医疗保健领域对PET 和SPECT 扫描仪创建断层扫描影像的需求不断增长,以及医疗保健领域的进步,是推动市场发展的一些关键因素。
自动放射合成模组是指先进的医疗设备,旨在以示踪剂分子配製放射性同位素,适合执行密集的诊断和治疗程序。自动放射合成模组也采用正子断层扫描(PET)和单光子发射电脑断层扫描(SPECT)扫描仪。这些解决方案提高了断层成像诊断方法的实用性。与放射性示踪剂和放射性药物装置相比,它在执行诊断和治疗管理时提供了更好的生产定制范围、更长的设备寿命、设置便利性以及更好的操作效率。除此之外,自动放射合成模组易于使用并改善治疗监测活动。因此,它被医疗保健从业者广泛应用于医院、实验室和诊所。目前,自动放射合成模组已商业化,有全自动和半自动两种类型。
包括癌症和慢性阻塞性肺病(COPD)在内的各种慢性和心血管疾病的盛行率不断增加,是推动市场成长的主要因素。此外,医疗保健领域对 PET 和 SPECT 扫描仪创建断层影像的需求不断增长,促进了医疗保健领域对自动放射合成模组的需求,这是另一个成长诱导因素。与此一致的是,一些政府在分散环境中对放射性示踪剂生产的大规模投资进一步促进了市场成长。此外,人们对多种产品优势(例如低资本成本、最低基础设施要求和最佳性能)的认识不断提高,正在支持市场成长。这可以进一步归因于其用途、功能和功效方面的重大技术进步,这极大地有利于市场成长。此外,易患慢性病的老年人口不断增加,以及全球死亡率不断上升,正在推动市场成长。其他因素,例如医疗保健基础设施的显着增强、最近的研发(R&D) 活动以及主要参与者之间为设计具有更高功效的新产品替代品而进行的重大战略合作,正在为市场增长创造积极的前景。该市场还受到医疗保健行业的显着扩张以及政府和私人组织提供的资金和赠款的推动,以鼓励在各种应用中采用自动放射合成模组。
The global automated radiosynthesis module market size reached US$ 34.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.72% during 2024-2032. The increasing prevalence of various chronic and cardiovascular diseases, especially amongst the geriatric population, along with the rising need for PET and SPECT scanners in the healthcare sector to create tomographic images and advancements in the healthcare sector represent some of the key factors driving the market.
Automated radiosynthesis module refers to advanced medical equipment designed to formulate the radioactive isotope with a tracer molecule that is suitable to perform intensive diagnostic and therapeutic procedures. The automated radiosynthesis module also employs positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scanners. These solutions improve the utility of tomographic imaging diagnostics methods. As compared to radiotracers and radiopharmaceutical units, it offers better scope for production customization, longer device life, setting-up convenience, and better operational efficiency while performing diagnosis and therapy administration. Along with this, the automated radiosynthesis module is readily usable and improves therapy monitoring activities. Consequently, it is extensively used across hospitals, laboratories, and clinics by healthcare practitioners. At present, automated radiosynthesis module is commercially available in full and semi-automated types.
The increasing prevalence of various chronic and cardiovascular diseases, including cancer and chronic obstructive pulmonary disorders (COPD), represents a prime factor driving the market growth. Additionally, the rising need for PET and SPECT scanners in the healthcare sector to create tomographic images have facilitated the demand for automated radiosynthesis module in the healthcare sector, which is acting as another growth-inducing factor. In line with this, the large-scale investments being made by several governments in the production of radiotracers in decentralized settings are further contributing to the market growth. Moreover, the rising awareness regarding the multiple product benefits, such as low capital cost, minimal infrastructural requirement, and optimal performance, is supporting the market growth. This can be further attributed to significant technological advancements in terms of its usage, features, and efficacy, which is considerably favoring the market growth. Additionally, the rising geriatric population, which is susceptible to chronic ailments, and the escalating mortality rates across the globe are propelling the market growth. Other factors, such as significant enhancements in the healthcare infrastructure, the recent research and development (R&D) activities, and the major strategic collaborations amongst key players to engineer new product alternatives with enhanced efficacy, are creating a positive outlook for the market growth. The market is also being driven by the significant expansion in the healthcare industry, along with funding and grants provided by government and private organizations to encourage the adoption of automated radiosynthesis module for various applications.
IMARC Group provides an analysis of the key trends in each segment of the global automated radiosynthesis module market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type and application.
Fully Automated
Semi-Automated
The report has also provided a detailed breakup and analysis of the automated radiosynthesis module market based on the type. This includes fully and semi-automated. According to the report, fully automated represented the largest segment.
Hospitals
Diagnostic Labs
Radiology Clinics
Others
A detailed breakup and analysis of the automated radiosynthesis module market based on the application has also been provided in the report. This includes hospitals, diagnostic labs, radiology clinics, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for automated radiosynthesis module. Some of the factors driving the North America automated radiosynthesis module market included the increasing prevalence of various chronic and cardiovascular diseases, significant technological advancements, and extensive research and development (R&D) activities.
The report has also provided a comprehensive analysis of the competitive landscape in the global automated radiosynthesis module market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Eckert & Ziegler Strahlen- und Medizintechnik AG, Elysia S.A., General Electric Company, IBA RadioPharma Solutions, Optimized Radiochemical Applications, SCINTOMICS Molecular, Applied Theranostics Technologies GmbH, Synthra GmbH, Trasis, etc.